ban on tirzepatide FDA Announces End To Compounded By March 19, 2025 The FDA is considering banning

The drug semaglutide is a game-changer in the weight loss ind

GLP-1 drugs curb appetite, but raise protein needs

This review explores the safety, efficacy, and clinical outcomes of these interventions on weight reduction, hormonal balance, menstrual regularity, and metabolic outcomes in both obese and non-obese women with PCOS.

Although certain commonly used hidradenitis suppurativa medications, such as tetracyclines and spironolactone, are contraindicated during pregnancy, there are still various medical therapies, including topicals, systemic antibiotics, metabolic modulators, and biologics, as well as procedural therapies that may be utilized during pregnancy

GIP Receptor Antagonism (Blocking): Unlike many dual-agonists that activate GIP, MariTide blocks it

Short-term semaglutide use can jumpstart weight loss when combined with lifestyle changes and proper medical oversight